TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.

F Janku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.